Xvivo Perfusion AB (publ) (LON:0RKL)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	279.94	415.52	546.09	246.55	398.7	354.24
Cash & Short-Term Investments	279.94	415.52	546.09	246.55	398.7	354.24
Cash Growth	-37.79%	-23.91%	121.50%	-38.16%	12.55%	121.47%
Accounts Receivable	153.65	117.29	98.13	94.5	52.04	40.18
Other Receivables	-	23.74	20.25	9.76	11.88	3.52
Receivables	153.65	141.04	118.37	104.26	63.91	43.7
Inventory	284.53	227.41	141.6	106.57	77.59	59.35
Prepaid Expenses	-	29.11	20.34	10.14	7.34	5.94
Total Current Assets	718.12	813.08	826.41	467.51	547.53	463.23
Property, Plant & Equipment	207.74	149.04	97.55	47.58	26.3	21.33
Long-Term Investments	-	0.9	0.58	0.41	1.16	0.75
Goodwill	622.56	682.48	591.39	625.32	460.23	223.94
Other Intangible Assets	41.01	48.7	30.46	8.49	8.66	6.75
Long-Term Deferred Tax Assets	-	32.45	50.71	39.27	42.17	40.33
Long-Term Deferred Charges	765.72	676.09	598.51	544.51	456.55	393.97
Total Assets	2,377	2,403	2,196	1,733	1,543	1,150
Accounts Payable	-	39.45	36.05	38.47	21.45	14.47
Accrued Expenses	-	85.08	68.94	52.65	46.96	48.9
Current Portion of Leases	-	10.92	10.27	5.55	4.2	3.93
Current Income Taxes Payable	-	11.93	11.87	1.28	0.3	-
Current Unearned Revenue	-	13.47	3.69	3.17	3.01	3.72
Other Current Liabilities	122.7	16.67	3.66	33.77	28.6	1.24
Total Current Liabilities	132.65	177.51	134.49	134.9	104.52	72.25
Long-Term Leases	-	23.13	21.17	4.46	1.52	3.29
Long-Term Deferred Tax Liabilities	-	27.85	29.29	25.77	25.08	24.85
Other Long-Term Liabilities	36.23	17.48	65.62	137.83	126.02	41.46
Total Liabilities	283.45	245.97	250.57	302.95	257.15	141.85
Common Stock	0.82	0.81	0.81	0.76	0.75	0.73
Additional Paid-In Capital	1,780	1,772	1,764	1,314	1,253	1,007
Retained Earnings	285.26	291.76	119.57	27.75	9.28	1.13
Comprehensive Income & Other	27.17	92.19	60.89	87.78	22.09	-0.18
Shareholders' Equity	2,094	2,157	1,945	1,430	1,285	1,008
Total Liabilities & Equity	2,377	2,403	2,196	1,733	1,543	1,150
Total Debt	124.53	34.04	31.44	10.01	5.72	7.21
Net Cash (Debt)	155.42	381.48	514.65	236.54	392.98	347.02
Net Cash Growth	-63.47%	-25.88%	117.58%	-39.81%	13.24%	124.76%
Net Cash Per Share	4.92	12.05	17.19	8.01	13.58	12.77
Filing Date Shares Outstanding	31.5	31.5	31.5	29.83	29.5	28.72
Total Common Shares Outstanding	31.5	31.5	31.5	29.83	29.5	28.72
Working Capital	585.48	635.57	691.92	332.61	443.01	390.98
Book Value Per Share	66.47	68.47	61.75	47.94	43.58	35.11
Tangible Book Value	1,430	1,426	1,323	796.33	816.56	777.77
Tangible Book Value Per Share	45.40	45.26	42.01	26.69	27.68	27.08
Machinery	-	217.57	153.61	98.52	68.04	58.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.